高级检索
当前位置: 首页 > 详情页

Monocyte Chemoattractant Protein-Induced Protein 1 Targets Hypoxia-Inducible Factor 1 alpha to Protect Against Hepatic Ischemia/Reperfusion Injury

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Gen Surg, Shanghai, Peoples R China [2]Wuhan Univ, Med Res Inst, Sch Med, Wuhan, Hubei, Peoples R China [3]Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Dept Cardiol,Fuwai Hosp, Beijing, Peoples R China [4]Peking Union Med Coll, Beijing, Peoples R China [5]Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China [6]Wuhan Univ, Zhongnan Hosp, Dept Hepatobiliary Surg, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China
出处:
ISSN:

摘要:
Sterile inflammation is an essential factor causing hepatic ischemia/reperfusion (I/R) injury. As a critical regulator of inflammation, the role of monocyte chemoattractant protein-induced protein 1 (MCPIP1) in hepatic I/R injury remains undetermined. In this study, we discovered that MCPIP1 downregulation was associated with hepatic I/R injury in liver transplant patients and a mouse model. Hepatocyte-specific Mcpip1 gene knockout and transgenic mice demonstrated that MCPIP1 functions to ameliorate liver damage, reduce inflammation, prevent cell death, and promote regeneration. A mechanistic study revealed that MCPIP1 interacted with and maintained hypoxia-inducible factor 1 alpha (HIF-1 alpha) expression by deubiquitinating HIF-1 alpha. Notably, the HIF-1 alpha inhibitor reversed the protective effect of MCPIP1, whereas the HIF-1 alpha activator compensated for the detrimental effect of MCPIP1 deficiency. Thus, we identified the MCPIP1-HIF-1 alpha axis as a critical pathway that may be a good target for intervention in hepatic I/R injury. (HEPATOLOGY 2018;68:2362-2379).

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
JCR分区:
出版当年[2016]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Gen Surg, Shanghai, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [3]Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Dept Cardiol,Fuwai Hosp, Beijing, Peoples R China [4]Peking Union Med Coll, Beijing, Peoples R China [6]Wuhan Univ, Zhongnan Hosp, Dept Hepatobiliary Surg, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China [*1]Department of Hepatobiliary Surgery Zhongnan Hospital of Wuhan University 169 Donghu Road Wuhan 430071, China [*2]Fuwai Hosp, Dept Cardiol, 167 Beilishi Rd, Beijing 100037, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25471 今日访问量:0 总访问量:1498 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)